Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Capital Reinvestment Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Capital Reinvestment Ratio of 7.78x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥24.04 Million) in capital expenditures (CN¥187.14 Million). See 301126 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Capital Reinvestment Ratio (2019–2024)
This chart tracks Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Capital Reinvestment Ratio across 3 annual periods. Check 301126 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2024. For live market cap and broader valuation context, see 301126 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.78x | CN¥24.04 Million | CN¥187.14 Million | ▼ -6.8% |
| 2023 | 8.36x | CN¥27.13 Million | CN¥226.70 Million | ▲ +3394.0% |
| 2019 | 0.24x | CN¥135.91 Million | CN¥32.50 Million | — |